HEMEDEX INC.

medical devices

About

HEMEDEX INC. was founded in 2000 to commercialize a proprietary platform technology conceived at the Massachusetts Institute of Technology (MIT) to quantify tissue perfusion (i.e., blood flow at the capillary level). This technology addresses the need for real-time, prognostic data in complex medical and surgical procedures. These complex procedures often involve compromised vasculature, delayed ischemia, or other serious pathophysiology, resulting in high rates of morbidity, delayed recuperation, poor patient outcome and higher overall costs. HEMEDEX's patented technology can provide an early warning of impending tissue ischemia, help target appropriate therapies, and rapidly assess the effect of interventions on cerebral blood flow (CBF), thus providing clinicians with a powerful tool to enhance patient care. HEMEDEX is ISO 13485:2012 certified.

Technologies

Outlook Microsoft Office 365 Apache YouTube Shutterstock WordPress.org Mobile Friendly Remote

Keywords

traumatic brain injury neurocritical care subarachnoid hemorrhage thermal conductivity perfusion neurosurgery neurointensive care multilumen bolt kit parenchymal cbf brain temperature medical equipment manufacturing thermal properties of tissue proprietary platform technology healthcare equipment & supplies thermal diffusion microprobe bowman perfusion monitor intracranial monitoring vasospasm detection medical devices microprocessor-based instrumentation medical equipment and supplies manufacturing brain tissue thermal conductivity thermal diffusion technology cranial bolt kits cerebral microcirculation data analysis and visualization brain edema assessment microvascular perfusion assessment perfusion probes medical technology

Location

564 Main St, Waltham, Massachusetts, United States, 02452

Related Companies

Companies in the same industry